Clinical trial
Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
NCT00446420 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
- Lead sponsor
- Melbourne Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- February 29, 2008
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment